Tag: Beyfortus

All

Latest

Beyfortus Approved in China to Prevent RSV Infants

AstraZeneca and Sanofi’s Beyfortus (nirsevimab), a long-acting monoclonal antibody, has been approved in China for the prevention of respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) in neonates and infants entering or during their first RSV season.

All

Latest
Sorry, No Posts Found

All

Latest
Sorry, No Posts Found
Sorry, No Posts Found